4 hours ago - Hope for treating the novel coronavirus could be on the horizon, as the first US study of a drug to treat the illness is underway.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Wednesday, February 26, 2020
Trump urges calm even as US reports worrisome new virus case President Donald Trump says the U.S. is “very, very ready” for whatever the new coronavirus threat brings, even as health authorities warn Americans that more infections are coming By LAURAN NEERGAARD and RICARDO ALONSO-ZALDIVAR Associated Press
February 26, 2020 Pioneer Drug Maker Throws First Punch At Pharmacy Outsourcing Facilities (503b)
"Azurity Pharmaceuticals, Inc. — a pioneer drug company that markets its FDA-approved oral vancomycin hydrochloride solution, FIRVANQ® — has sued Edge Pharma, LLC, an outsourcing facility operating pursuant to section 503B of the Federal Food, Drug, and Cosmetic Act (FDCA), for compounding an oral vancomycin hydrochloride solution that is identical or nearly identical to FIRVANQ." More Here
Subscribe to:
Posts (Atom)